Carlyle Secured Lending (CGBD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Special Meeting scheduled for June 9, 2026, to vote on authorizing issuance of common stock below net asset value (NAV) for 12 months following approval, subject to limitations.
Board unanimously recommends voting in favor, citing flexibility to raise capital, repay debt, and pursue investment opportunities.
Proposal allows issuance of up to 25% of outstanding shares below NAV, with no limit on discount, to respond quickly to market conditions.
No immediate plans for such issuance; each transaction would require Board approval at the time of sale.
Voting matters and shareholder proposals
Only proposal on the agenda is to authorize issuance of shares below NAV; no other business will be conducted.
Approval requires majority of outstanding shares and majority of non-affiliated shares.
Abstentions and broker non-votes count as votes against the proposal.
Stockholder proposals for the 2027 annual meeting must be received by December 31, 2026, with specific bylaw requirements for nominations.
Board of directors and corporate governance
Board consists of interested and independent directors, with beneficial ownership disclosed for each.
Board and independent directors must approve any issuance below NAV as in the best interests of the company and shareholders.
No cumulative voting or appraisal rights for shareholders.
Latest events from Carlyle Secured Lending
- Proxy solicits shareholder votes on key governance and capital structure issues.CGBD
Proxy filing30 Apr 2026 - Annual proxy outlines voting proposals and governance, with no filing fee required.CGBD
Proxy filing30 Apr 2026 - 2026 meeting to elect directors, ratify auditor, and reinforce governance and compliance.CGBD
Proxy filing30 Apr 2026 - Shareholders will vote on authorizing share issuance below NAV to boost capital flexibility.CGBD
Proxy filing15 Apr 2026 - Record originations, stable NAV, and new JVs set the stage for higher returns in 2026.CGBD
Q4 202525 Feb 2026 - Q3 2024 delivered $0.47/share NII, $16.85 NAV/share, and a pending merger with CSL III.CGBD
Q3 20243 Feb 2026 - Q2 net investment income was $0.51/share, NAV $16.95, and a merger with CSL III was announced.CGBD
Q2 20242 Feb 2026 - Q4 net investment income held steady as portfolio, liquidity, and dividend coverage strengthened.CGBD
Q4 202423 Dec 2025 - Vote sought to authorize share issuance below NAV for up to 25% of shares over 12 months.CGBD
Proxy Filing1 Dec 2025